Our results indicate that LBW242 improves the sensitivity of ovarian cancer cell death induced by either TRAIL or anticancer drugs such as Topotecan through an effect related to a potentiation of caspase-8 activation. The gene discussed is TNFSF10; the disease is ovarian carcinoma.